ArticleJournal of hepatology2020
SARS-CoV-2: Is the liver merely a bystander to severe disease?
Abstract readLetterComment
In one paragraph
Article in Journal of hepatology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 2 of them syntheses that pooled it.
0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 2 pooled it
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
29 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Correlation between COVID-19 and hepatitis B: A systematic review.World journal of gastroenterology · 2022Pooled it
- Histopathological findings and clinicopathologic correlation in COVID-19: a systematic review.Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc · 2021Pooled it
- Evaluation of Biochemical Characteristics in a Retrospective Cohort of COVID-19 Patients.Cureus · 2024Article
- Asialoglycoprotein receptor 1 promotes SARS-CoV-2 infection of human normal hepatocytes.Signal transduction and targeted therapy · 2024Article
- Differences in clinical characteristics and liver injury between patients diagnosed with the Omicron subvariant BA.5.2 and the prototype of SARS-CoV-2: a single center retrospective study.BMC gastroenterology · 2023Article
- Unraveling the Molecular and Cellular Pathogenesis of COVID-19-Associated Liver Injury.Viruses · 2023Review
- The Intersection of COVID-19 and Metabolic-Associated Fatty Liver Disease: An Overview of the Current Evidence.Viruses · 2023Review
- COVID-19 and the liver: Are footprints still there?World journal of gastroenterology · 2023Review
- SARS-CoV-2 Infection and Liver Disease: A Review of Pathogenesis and Outcomes.Gut and liver · 2023Review
- COVID-19: Has the Liver Been Spared?International journal of molecular sciences · 2023Review
- Clinical and Histopathological Discoveries in Patients with Hepatic Injury and Cholangiopathy Who Have Died of COVID-19: Insights and Opportunities for Intervention.Hepatic medicine : evidence and research · 2023Review
- COVID-19-induced liver injury in adult patients: A brief overview.World journal of virology · 2022Review
- COVID-19 metabolism: Mechanisms and therapeutic targets.MedComm · 2022Review
- SARS-CoV-2 infection and liver involvement.Hepatology international · 2022Review
- Article
- Review
- Autoimmune hepatitis after COVID-19 vaccination.Frontiers in immunology · 2022Review
- Prevalence and Prognostic Impact of Deranged Liver Blood Tests in COVID-19: Experience from the Regional COVID-19 Center over the Cohort of 3812 Hospitalized Patients.Journal of clinical medicine · 2021Article
- COVID-19: a fatal case of acute liver failure associated with SARS-CoV-2 infection in pre-existing liver cirrhosis.BMC infectious diseases · 2021Article
- Abnormal liver tests in patients with SARS-CoV-2 or influenza - prognostic similarities and temporal disparities.JHEP reports : innovation in hepatology · 2021Article
Corrections and comments
- Commented on by
- Comment on
Authors and funding
9 authors.
Mansoor N BangashLiver Intensive Care Unit, Queen Elizabeth Hospital Birmingham, Mindelsohn Way, Birmingham, UK; Birmingham Liver Failure Research Group, Institute of Inflammation and Ageing, NIHR Biomedical Research Centre, University of Birmingham, Birmingham, UK; Birmingham Acute Care Research Group, Institute of Inflammation and Ageing, NIHR Biomedical Research Centre, University of Birmingham, Birmingham, UK. Electronic address: mansoor.bangash@uhb.nhs.uk.
Jaimin M PatelLiver Intensive Care Unit, Queen Elizabeth Hospital Birmingham, Mindelsohn Way, Birmingham, UK; Birmingham Liver Failure Research Group, Institute of Inflammation and Ageing, NIHR Biomedical Research Centre, University of Birmingham, Birmingham, UK; Birmingham Acute Care Research Group, Institute of Inflammation and Ageing, NIHR Biomedical Research Centre, University of Birmingham, Birmingham, UK.
Dhruv ParekhLiver Intensive Care Unit, Queen Elizabeth Hospital Birmingham, Mindelsohn Way, Birmingham, UK; Birmingham Liver Failure Research Group, Institute of Inflammation and Ageing, NIHR Biomedical Research Centre, University of Birmingham, Birmingham, UK; Birmingham Acute Care Research Group, Institute of Inflammation and Ageing, NIHR Biomedical Research Centre, University of Birmingham, Birmingham, UK.
Nicholas MurphyLiver Intensive Care Unit, Queen Elizabeth Hospital Birmingham, Mindelsohn Way, Birmingham, UK; Birmingham Liver Failure Research Group, Institute of Inflammation and Ageing, NIHR Biomedical Research Centre, University of Birmingham, Birmingham, UK; Birmingham Acute Care Research Group, Institute of Inflammation and Ageing, NIHR Biomedical Research Centre, University of Birmingham, Birmingham, UK.
Rachel M BrownBirmingham Liver Failure Research Group, Institute of Inflammation and Ageing, NIHR Biomedical Research Centre, University of Birmingham, Birmingham, UK; Department of Cellular Pathology, QEHB, Mindelsohn Way, Birmingham, UK; Institute of Inflammation and Ageing, NIHR Biomedical Research Centre, University of Birmingham, Birmingham, UK.
Ahmed M ElsharkawyBirmingham Liver Failure Research Group, Institute of Inflammation and Ageing, NIHR Biomedical Research Centre, University of Birmingham, Birmingham, UK; Institute of Inflammation and Ageing, NIHR Biomedical Research Centre, University of Birmingham, Birmingham, UK; Liver Unit, Queen Elizabeth Hospital Birmingham, Mindelsohn Way, Birmingham, UK.
Gautam MehtaInstitute for Liver and Digestive Health, Royal Free Campus, UCL, London, UK; Institute of Hepatology, Foundation for Liver Research, London, UK.
Matthew J ArmstrongBirmingham Liver Failure Research Group, Institute of Inflammation and Ageing, NIHR Biomedical Research Centre, University of Birmingham, Birmingham, UK; Institute of Inflammation and Ageing, NIHR Biomedical Research Centre, University of Birmingham, Birmingham, UK; Liver Unit, Queen Elizabeth Hospital Birmingham, Mindelsohn Way, Birmingham, UK.
Desley NeilBirmingham Liver Failure Research Group, Institute of Inflammation and Ageing, NIHR Biomedical Research Centre, University of Birmingham, Birmingham, UK; Department of Cellular Pathology, QEHB, Mindelsohn Way, Birmingham, UK; Institute of Inflammation and Ageing, NIHR Biomedical Research Centre, University of Birmingham, Birmingham, UK.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Coronavirus InfectionsPandemicsPneumonia, ViralBetacoronavirusCOVID-19HumansLiverSARS-CoV-2
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.